Adagio Medical Holdings (ADGM) Enterprise Value (2023 - 2026)

Adagio Medical Holdings (ADGM) has 4 years of Enterprise Value data on file, last reported at -$12.9 million in Q1 2026.

• Enterprise Value for Q1 2026 came in at -$12.9 million, changed 0.42% year-over-year; the trailing twelve-month figure through Mar 2026 was -$12.9 million (changed 0.42% YoY), and the FY2025 annual result was -$17.1 million, up 16.97% from the prior year.
• Enterprise Value climbed to -$12.9 million in Q1 2026 per ADGM's latest filing, from -$17.1 million in the prior quarter.
• Over five years, Enterprise Value peaked at -$1.4 million in Q4 2023 and troughed at -$28.3 million in Q3 2024.
• A 4-year average of -$13.3 million and a median of -$12.9 million in 2025 frame the typical range for Enterprise Value.
• The sharpest annual moves came in 2024 and 2025: Enterprise Value plunged 1389.52% in 2024, then surged 83.39% in 2025.
• A 4-year view of Enterprise Value shows it stood at -$1.4 million in 2023, then sank by 1389.52% to -$20.6 million in 2024, then gained by 16.97% to -$17.1 million in 2025, then grew by 24.53% to -$12.9 million in 2026.
• Business Quant data shows ADGM's Enterprise Value at -$12.9 million in Q1 2026, -$17.1 million in Q4 2025, and -$4.7 million in Q3 2025.